On the other hand, the pluripotency of GDF15 as a marker, being considered a diagnostic/prognostic index of obesity, cancer development, and response to chemotherapy, suggests the common pathway of action/activation with other molecules [2,5,22]. Here, GDF15 is linked to obesity due to melanocortin 4 receptor deficiency.